iifl-logo

PGIM India Healthcare Fund Regular G

PGIM India Healthcare Fund Regular G

Fund Name

PGIM India Mutual Fund

Scheme Name

PGIM India Healthcare Fund Regular G

AMC

PGIM India Mutual Fund

Type

:  Open

Category

Equity - Pharma

Launch Date

19-Nov-2024

Fund Manager

Anandha Padmanabhan Anjen

Net Assets (Rs. cr)

125.15

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

PGIM India Healthcare Fund Regular G - Nav Details

Nav Date

:  18-Sep-2026

NAV [Rs.]

:  12.16

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

Nil

Exit Load %

For Exits within 90 days from date of allotment of units: 0.50% For Exits beyond 90 days from date of allotment of units: NIL

PGIM India Healthcare Fund Regular G- NAV Chart

PGIM India Healthcare Fund Regular G- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
0.33
-0.16
10.34
23.57
22.21
-
-
11.58
Category Avg
0.54
0.78
9.47
21.66
16.01
20.68
14.49
16.98
Category Best
1.16
2.87
13.66
29.57
27.29
24.31
18.52
32.12
Category Worst
-0.11
-0.81
3.51
10.56
3.57
16.54
11.39
0.39

PGIM India Healthcare Fund Regular G- Latest Dividends

No Records Found

PGIM India Healthcare Fund Regular G- Investment Details

Min. Investment(Rs.)

5000

Increm.Investment(Rs.)

1000

In & Out

In

InName Of The CompanyNo Of Shares
Gland Pharma3,175
Ipca Labs.3,210

Out

InName Of The CompanyNo Of Shares
--

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquityDivi's Lab.Pharmaceuticals & Biotechnology10.851433913.57
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology10.746768813.43
EquityTorrent Pharma.Pharmaceuticals & Biotechnology8.862188611.08
EquityMax HealthcareHealthcare Services4.96595646.20
EquityAjanta PharmaPharmaceuticals & Biotechnology4.83167656.03
EquityManipal HealthHealthcare Services4.12676465.16
EquityMankind PharmaPharmaceuticals & Biotechnology4.07210455.09
EquityRubicon ResearchPharmaceuticals & Biotechnology4.01275905.02
EquityDr Lal PathlabsHealthcare Services3.93254324.92
EquityNeuland Labs.Pharmaceuticals & Biotechnology3.2617744.08
EquityKrishna Institu.Healthcare Services3.15522473.94
EquityNavin Fluo.Intl.Chemicals & Petrochemicals3.0443923.81
EquityAster DM QualityHealthcare Services2.89478913.62
EquityAbbott IndiaPharmaceuticals & Biotechnology2.8313683.53
EquitySai LifePharmaceuticals & Biotechnology2.54217563.17
EquityCiplaPharmaceuticals & Biotechnology2.23197712.78
EquityPfizerPharmaceuticals & Biotechnology2.1256652.65
EquityAnthem BiosciencPharmaceuticals & Biotechnology1.96274572.45
EquityJupiter Life LinHealthcare Services1.77749502.21
EquityGlobal HealthHealthcare Services1.72145512.15
EquityZydus Lifesci.Pharmaceuticals & Biotechnology1.51162551.88
EquityLupinPharmaceuticals & Biotechnology1.4281201.77
EquityICICI LombardInsurance1.40111631.74
EquityDr Agarwal's EyeHealthcare Services1.2028441.49
EquityFortis Health.Healthcare Services1.10151601.37
EquityDr Agarwal's HeaHealthcare Services0.86209401.07
EquityOrchid PharmaPharmaceuticals & Biotechnology0.80102850.99
EquityGland PharmaPharmaceuticals & Biotechnology0.7331750.91
EquityLenskart Solut.Retailing0.71135010.89
EquityIpca Labs.Pharmaceuticals & Biotechnology0.5132100.63
EquitySagilityIT - Services0.461226240.57

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
PGIM India Mutual Fund
Incorporation Date:
24-Sep-2008
Total Assets Managed (Cr.):
26,639.93
Trustee/s:
Rakesh Sood, PGIM India Trustees Priva, Mr. Vijay Agarwal, Mr. Sujal Shah, Mr. John Praveen, Mr. Ashwini Kakkar
Chairman:
NA
CEO / MD:
Ajit Menon, Abhishek Tiwari
CIO:
NA
President:
NA
Director/s:
Glenwyn Peter Baptist, Kapil Wadhawan, Mr.David Wan Chang, Mr.Indrasena Yala Reddy, Dr. V. R. Narasimham, Mr.Muralidharan Rajamani
Compliance Officer/s:
Mr. Sandeep Kamath, Mr. Sumesh Kumar
Investor Service Officer/s:
Murali Ramasubramanian
Fund Manager/s:
Anandha Padmanabhan Anjen
Auditors:
Price Waterhouse Chartere

OTHER INFORMATION

Registered Office:
4th Floor, C Wing, Laxmi Towers, Bandra Kurla Complex, Bandra (East), Mumbai - 400 051
Contact Nos:
022-61593000
Fax:
022-61593100
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.